Apogee Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Apogee Therapeutics, Inc. (APGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.56 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-10
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 163.07K shares, a 60.31% decline year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.40M shares, a 406.60% increase year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 125.15K shares, a 93.41% decline year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 124.59K shares, a 63.45% decline year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 936.15K shares, a 65.67% decline from fiscal 2024.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.73M shares, a 8.26% increase from fiscal 2023.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.52M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 163.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 1.56M shares 10-Q · filed 2026-08-10 | 1.68M shares derived: sum of 3 quarters · filed 2026-08-10 | 1.81M shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 1.40M shares 10-Q · filed 2026-05-11 | 1.52M shares derived: sum of 2 quarters · filed 2026-05-11 | 1.65M shares derived: sum of 3 quarters · filed 2026-05-11 | 2.06M shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 125.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 249.75K shares derived: sum of 2 quarters · filed 2026-03-02 | 660.61K shares derived: sum of 3 quarters · filed 2026-03-02 | 936.15K shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 124.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 535.46K shares derived: sum of 2 quarters · filed 2025-11-10 | 811.00K shares 10-Q · filed 2025-11-10 | 2.71M shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 410.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 686.40K shares 10-Q · filed 2025-08-11 | 2.58M shares derived: sum of 3 quarters · filed 2025-08-11 | 2.93M shares derived: sum of 4 quarters · filed 2025-08-11 |
| 2025-03-31 | 275.54K shares 10-Q · filed 2025-05-12 | 2.17M shares derived: sum of 2 quarters · filed 2025-05-12 | 2.51M shares derived: sum of 3 quarters · filed 2025-05-12 | 2.89M shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 1.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 2.24M shares derived: sum of 2 quarters · filed 2025-03-03 | 2.62M shares derived: sum of 3 quarters · filed 2025-03-03 | 2.73M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 340.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 718.25K shares derived: sum of 2 quarters · filed 2024-11-12 | 828.51K shares 10-Q · filed 2024-11-12 | 2.71M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 377.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 487.59K shares 10-Q · filed 2024-08-12 | 2.37M shares derived: sum of 3 quarters · filed 2024-08-12 | -1.62M shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 110.26K shares 10-Q · filed 2024-05-13 | 1.99M shares derived: sum of 2 quarters · filed 2024-05-13 | -1.99M shares derived: sum of 3 quarters · filed 2024-05-13 | |
| 2023-12-31 | 1.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -2.10M shares derived: sum of 2 quarters · filed 2024-03-05 | 2.52M shares 10-K · filed 2024-03-05 | |
| 2023-09-30 | -3.98M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 637.55K shares 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | 4.62M shares 10-Q · filed 2023-08-28 |